St. Jude Medical-backed Nanostim drums up $10M | Wall Street Beat

October 18, 2012 by MassDevice staff

Nanostim, which is backed by St. Jude Medical, raises $10 million for a leadless pacemaker designed to be implanted directly in the heart. Wall Street Beat

Nanostim, the Sunnyvale, Calif.-based company that's developing a leadless pacemaker, raised $10 million in an equity and options deal, according to a regulatory filing.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.